💸 The Tape

Governor Abigail Spanberger (D) returned the state's recreational marijuana sales bill to legislators on Monday with a package of proposed amendments, the most significant being a delay of the launch date from January 1, 2027 to July 1, 2027. Her reasoning: the extra time is needed to "implement a legal market safely and curb the illicit market."

It's not a veto. It's not a rejection. But for an industry and a state that's been waiting five years for this moment, another six months of patience is a tough ask.

The Long Road Here

Virginia legalized personal marijuana possession and home cultivation back in 2021, making adults over 21 free to hold up to an ounce and grow their own plants. What didn't come with that law was any mechanism to actually buy cannabis legally. Former Governor Glenn Youngkin (R) vetoed sales legislation twice during his tenure, leaving the state in a peculiar limbo: you could have it, grow it, even gift it — but purchasing it through a regulated storefront remained illegal.

That changed when the legislature sent SB 542 from Sen. Lashrecse Aird (D) and HB 642 from Del. Paul Krizek (D) to Spanberger's desk. The bills represented the most comprehensive framework Virginia had produced for a regulated adult-use market. Spanberger's amendments don't dismantle that framework — they adjust it.

Virginia is closer to legal cannabis sales than it's ever been — but the finish line just moved back six months.

Governor Abigail Spanberger (D) returned the state's recreational marijuana sales bill to legislators on Monday with a package of proposed amendments, the most significant being a delay of the launch date from January 1, 2027 to July 1, 2027. Her reasoning: the extra time is needed to "implement a legal market safely and curb the illicit market."

It's not a veto. It's not a rejection. But for an industry and a state that's been waiting five years for this moment, another six months of patience is a tough ask.

The Long Road Here

Virginia legalized personal marijuana possession and home cultivation back in 2021, making adults over 21 free to hold up to an ounce and grow their own plants. What didn't come with that law was any mechanism to actually buy cannabis legally. Former Governor Glenn Youngkin (R) vetoed sales legislation twice during his tenure, leaving the state in a peculiar limbo: you could have it, grow it, even gift it — but purchasing it through a regulated storefront remained illegal.

That changed when the legislature sent SB 542 from Sen. Lashrecse Aird (D) and HB 642 from Del. Paul Krizek (D) to Spanberger's desk. The bills represented the most comprehensive framework Virginia had produced for a regulated adult-use market. Spanberger's amendments don't dismantle that framework — they adjust it.

What the Governor Wants Changed

Beyond the delayed start date, Spanberger is proposing to reduce the personal possession limit from the legislature's proposed two and a half ounces down to two ounces — still double the current one-ounce cap, but a more conservative step. She's also looking to strengthen enforcement provisions with a particular focus on consumer and product safety, and took a pointed shot at vape shops she says have spent years "targeting Virginia's kids."

"We need to rein in these shady businesses and make sure a legal marijuana market does not make the problem worse," Spanberger said.

Lawmakers will reconvene on April 22 to address the governor's proposals. Given that the legislature already passed the bills with enough support to reach her desk, the amendments are likely to generate debate but not derail the broader effort.

The Framework on the Table

Even with Spanberger's adjustments, the legislation outlines one of the more carefully constructed adult-use markets in the country. Here's what consumers and businesses can expect if the final version passes.

The Virginia Cannabis Control Authority would oversee licensing and regulation, and would also absorb oversight of hemp — currently managed by the Department of Agriculture and Consumer Services. That consolidation is a notable structural choice, centralizing cannabis governance under a single regulatory body.

On the tax side, the state would impose a 6% excise tax alongside a 5.3% retail sales and use tax, with municipalities allowed to tack on an additional local tax of up to 3.5%. The combined rate puts Virginia in a moderate range compared to other legal states — high enough to generate meaningful revenue, but not so punitive that it drives consumers back to the illicit market.

Revenue distribution follows a socially conscious formula: 40% to early childhood education, 30% to the Cannabis Equity Reinvestment Fund, 25% to the Department of Behavioral & Developmental Health Services, and 5% to public health initiatives. That allocation tells you a lot about the political compromises required to move cannabis legislation in a purple state.

Other details round out the picture. Delivery services would be permitted. Serving sizes for edibles would be capped at 10 mg THC per serving with a 100 mg maximum per package. Existing medical cannabis operators could convert to adult-use licenses for a hefty $10 million conversion fee — a figure that will undoubtedly spark debate about whether that threshold protects the market or simply entrenches well-capitalized incumbents.

Notably, local governments would not be able to opt out of allowing marijuana businesses in their jurisdictions — a provision that avoids the patchwork problem that has hobbled markets in states like New Jersey and New York, where municipal opt-outs created vast retail deserts.

A legislative commission would also study future additions, including on-site consumption licenses, microbusiness cannabis event permits for venues like farmers markets and pop-ups, and the potential involvement of the Virginia Alcoholic Beverage Control Authority in marijuana regulation. Those studies signal that legislators see the initial framework as a foundation, not the final product.

What Spanberger Signed

While the sales bill awaits its next chapter, the governor didn't leave Monday empty-handed. Spanberger signed several related cannabis measures, including bills to protect the parental rights of cannabis consumers and to allow patients to access medical marijuana in hospitals — a provision that mirrors the kind of institutional acceptance recently advanced in Louisiana. She also proposed amendments to legislation addressing resentencing relief for individuals with past cannabis convictions and adjustments to medical cannabis delivery rules.

The Bigger Picture

Virginia's path to legal sales has been unusually drawn out, even by cannabis legislation standards. Five years of possession without purchase created a gray market that thrived in the absence of regulation — exactly the kind of environment that makes launching a clean, competitive legal market harder, not easier.

Spanberger's decision to push the start date back to July 2027 is frustrating for businesses that have been waiting years to operate, but it reflects a pragmatic reality: rushing a market open with insufficient regulatory infrastructure risks repeating the mistakes that plagued early launches in states like California and New York, where illicit operators continued to dominate long after legalization.

The April 22 reconvening will determine whether legislators accept the governor's amendments or push back. Either way, the trajectory is clear. Virginia is no longer debating whether to allow legal cannabis sales — only when and how. For a state that spent half a decade stuck between legalization and implementation, that distinction matters more than a six-month delay.

The wait continues. But the destination, finally, looks certain.

Source: Marijuana Moment

📈 Dog Walkers

$ROMJF Enters The U.K.

Rubicon Organics has announced that its award-winning 1964 Supply Co.™ brand is entering the UK medical cannabis market through a distribution partnership with 4C LABS. The deal marks the brand's first international route-to-market for medical products, building on successful wholesale exports in 2025 and expanding Rubicon's total addressable market beyond Canadian borders.

Under the partnership, 4C LABS will facilitate patient access to 1964 Supply Co.™ products through its network of cannabis clinics and regulated distributors across the UK. The initial lineup includes organically grown flower, vapes, and extracts, with plans to expand the portfolio in the coming months as demand grows.

CEO Margaret Brodie framed the move as a natural extension of years of investment in brand and cultivation. "The U.K. is a rapidly growing medical cannabis market where quality and consistency truly matter," she said, noting that additional capacity from Rubicon's Cascadia facility will support scaled production without sacrificing the standards the brand is known for.

1964 Supply Co.™ has built serious credibility at home. The brand has won Brand of the Year at the KIND Awards for two consecutive years and is rooted in classic legacy genetics with a focus on delivering genuine, high-quality cannabis. Translating that reputation into a medical context in a new market is the next logical step — and one that could open the door for further international expansion.

The UK medical cannabis market has been gaining momentum steadily, and patients there are increasingly seeking premium, consistent products from trusted sources. For Rubicon, landing 1964 Supply Co.™ in British clinics isn't just a distribution deal — it's a proof of concept for taking a Canadian premium brand global.

$GLASF ( ▼ 1.81% ) & $VREOF ( ▼ 1.83% ) Team Up In Cali

Two of California's most prominent cannabis operators are joining forces — and the resulting platform could reshape how the state's legal market competes for consumers.

Glass House Brands and Vireo Growth have announced a 50/50 joint venture that will combine their respective California dispensary operations into one of the state's largest retail networks. Glass House brings eleven retail locations and its reputation as California's most efficient large-scale cannabis producer. Vireo contributes twelve dispensaries plus home delivery operations acquired from Eaze, one of the industry's most recognized technology-driven delivery platforms.

The math is straightforward: 23 dispensaries, an integrated delivery infrastructure, and a preferential supply agreement with Glass House's low-cost cultivation operation feeding product into the network. After five years, Vireo holds an option to acquire Glass House's equity stake, with Glass House retaining a reciprocal put right.

Cory Azzalino, Vireo's President of California, has been named CEO of the joint venture, tasked with overseeing operations and leading an acquisition and expansion strategy that signals this is just the starting lineup.

Glass House CEO Kyle Kazan framed the deal as a way to navigate California's notoriously difficult pricing dynamics without distracting from the company's core mission of pushing biomass into new legal markets outside the state. "Vireo brings exceptional retail reach and delivery infrastructure," he said, "while Glass House contributes proven retail execution, low-cost production, and deep brand equity."

Vireo CEO John Mazarakis was equally bullish, calling Glass House "the ideal partner" and describing the combined entity as "greater than the sum of its parts" — a venture built to serve more consumers, support independent brands, and attract operators looking for a well-capitalized home.

The Eaze delivery platform is a particularly strategic asset. It extends the joint venture's reach into areas with limited retail access, offering competitive pricing that could help draw consumers away from the illicit market — a persistent challenge in California where unlicensed operators continue to undercut legal businesses.

For a state that remains the world's largest legal cannabis market yet has frustrated operators with razor-thin margins, regulatory complexity, and stubborn black-market competition, the Glass House-Vireo playbook makes a compelling case: consolidate, integrate, and compete on both price and reach. Whether this becomes a model for California's next chapter or simply a survival strategy dressed in optimistic language will depend on execution — but the pieces, on paper, fit.

🗞️ The News

📺 YouTube

Texas Hemp Ban Paused as Legal Fight Escalates | TTB Presented by Flowhub

What we will cover:

✅ In this Trade To Black livestream presented by Flowhub, host Shadd Dales and Anthony Varrell sit down with Michael Bronstein, President of the American Trade Association for Cannabis and Hemp, for another round of the Weekly Insider’s Edge — and there’s a lot happening right now.

First up — Texas.

A judge has officially paused new rules that would have banned smokable hemp products like THCA flower. That’s a significant move, and it makes one thing very clear: this fight is far from over. Expect it to play out state by state for a while.

On the federal side, things are getting interesting too.
RFK Jr. and Dr. Mehmet Oz are pushing to dismiss a lawsuit trying to block a Medicare pilot program connected to hemp-derived CBD and low-dose THC. That’s not a small thing — it signals that cannabinoids are quietly working their way deeper into the healthcare system, legal battles and all.